Palmetto

Apollon Wealth Management Honored Among USA Today’s Best Financial Advisory Firms for 2024

Retrieved on: 
tisdag, maj 7, 2024
Finance, Publishing, Consulting, Public Relations, Investor Relations, Banking, Communications, Professional Services, Media, Asset Management, Apollon, Statista, Best, Federal Reserve, RIAS, Federal, Partnership, South, USA Today, AUM, Palmetto, Growth

For the second year in a row, USA Today has recognized Apollon Wealth Management, a leading Charleston-based financial advisory firm under Apollon Holdings, as one of the Best Financial Advisory Firms of 2024 .

Key Points: 
  • For the second year in a row, USA Today has recognized Apollon Wealth Management, a leading Charleston-based financial advisory firm under Apollon Holdings, as one of the Best Financial Advisory Firms of 2024 .
  • The growth of assets under management and recommendations from clients and peers determine the rankings, which puts Apollon Wealth Management in the Top 100.
  • “Receiving this recognition as one of the Best Financial Advisory Firms 2024 by USA Today for a second time is a great honor,” said Michael Dolberg, founding partner and CEO of Apollon Wealth Management.
  • To learn more about Apollon Wealth Management, visit https://apollonwealthmanagement.com/ .

SCbio's Life Science Accelerator, SCbioDrive, Launches Application for Inaugural Cohort

Retrieved on: 
tisdag, maj 7, 2024
Charles River Laboratories, Drive, Partnership, Research, Curriculum, Therapy, Science, Economic development, Multimedia, Palmetto, Organization, Growth, Management

Emerging therapeutics companies are invited to apply for the inaugural Fall 2024 program by June 28.

Key Points: 
  • Emerging therapeutics companies are invited to apply for the inaugural Fall 2024 program by June 28.
  • "The resources and knowledge that the SCbioDrive inaugural cohort will gain from the expert companies leading this curriculum will be invaluable," said SCbio President and CEO James Chappell.
  • Applications for the inaugural program cohort are available at www.scbio.org/scbiodrive .
  • SCbio is South Carolina's investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.

Concert Announces Clinical Advisory Board, New Medical Policies

Retrieved on: 
onsdag, maj 1, 2024
Cepheid variable, FDA, Biochemistry, Doctor of Philosophy, Cardiovascular disease, Vanderbilt University Medical Center, Associate, Palmetto, Prevalence, Concert, Global health, Congress, COVID, CRS, Food, Princeton University, Yale University, DRS, Duke University, Microbiology, Infection, Assistant, Molecular biology, Humana, Staphylococcus, Congressional Research Service, MD–PhD, Health, Library, Neuroscience, Research, Personalized medicine, Emory School, Public policy, Immunology, Medicine, Health policy, Maryland School, Government, Division, Rice University, University, Goucher College, Public health, MD, Duke, Staphylococcus aureus, Wake Forest University, Patient, Internal medicine

NASHVILLE, Tenn., May 1, 2024 /PRNewswire/ -- As part of its commitment to provide transparent, evidence-based medical policy and enable accurate reimbursement for a broader set of diagnostic services, Concert today announced the establishment of an advisory board of experts in clinical laboratory medicine and the release of policies for an expanded scope of routine and advanced laboratory testing.

Key Points: 
  • The newly formed board will advise Concert on its clinical laboratory content.
  • "Concert is working to align payers, providers, and labs to enable patient access to evidence-based testing," said Dr. Girish Putcha.
  • Following are brief bios on each member of the new clinical advisory board, in alphabetical order by last name.
  • Recent roles include Director of Laboratory Science at Palmetto's MolDX program, Chief Medical Officer and Clinical Laboratory Director of Freenome, and Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) member.

AESC Expands Manufacturing Operations in Florence County

Retrieved on: 
tisdag, mars 26, 2024
EV, Electric Vehicles, Other Energy, Batteries, Alternative Energy, Energy, Technology, State, Local, Automotive, Other Manufacturing, Automotive Manufacturing, Manufacturing, Public Policy, Government, Growth, Duke Energy, Palmetto, Partnership, Committee, BMW, Ecosystem, Renewable energy

AESC (the “Company”), a world-leading battery technology company, today announced the expansion of its lithium-ion electric vehicle battery manufacturing operations in Florence County.

Key Points: 
  • AESC (the “Company”), a world-leading battery technology company, today announced the expansion of its lithium-ion electric vehicle battery manufacturing operations in Florence County.
  • The AESC campus is located in the more than 1,000-acre Florence Global Technology Park.
  • Beyond the immediate impact on job creation, AESC's presence will catalyze a ripple effect across our local economy.” -Florence County Council Chair William Schofield
    “As we continue to move Florence forward, we celebrate AESC’s expansion and continued growth in Florence.
  • The continued momentum of AESC’s presence in Florence County brings even more high-level jobs and opportunities to residents of the region.

Duke Energy Progress looks to add solar power in eastern South Carolina as part of diverse plan to support booming growth

Retrieved on: 
fredag, mars 22, 2024
Electricity, United States Census Bureau, Nuclear, Natural gas, Duke Energy, Palmetto, Carbon accounting, News, Carbon, Investment, South, Hydrogen, Weather, Multimedia, Public Service Commission, Population growth, Renewable energy

The facility will provide fuel-free power to meet the growing needs of the Pee Dee region of South Carolina.

Key Points: 
  • The facility will provide fuel-free power to meet the growing needs of the Pee Dee region of South Carolina.
  • From population growth to the expansion of manufacturing and other major economic development wins, South Carolina is booming.
  • "This diverse mix will help Duke Energy meet customer expectations for cleaner energy while also reliably powering communities across the state."
  • Duke Energy Progress, a subsidiary of Duke Energy, owns 12,500 megawatts of energy capacity, supplying electricity to 1.7 million residential, commercial and industrial customers across a 29,000-square-mile service area in North Carolina and South Carolina.

Coastal Carolina University launches South Carolina’s first space satellite program

Retrieved on: 
onsdag, februari 28, 2024
Engineering, Tornado, Ansys, Security studies, Altitude, Social media, Research, Intelligence, Photograph, South, Humanities, Provost, Mathematics, Health, Climate change, Palmetto, Drinking water, STEAM, CCU, Coastal Carolina University, Science, LEO, CubeSat, Face, Student, Management

Conway, S.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Coastal Carolina University announces the launch of the CCU Space Program, the first such endeavor in South Carolina.

Key Points: 
  • Conway, S.C., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Coastal Carolina University announces the launch of the CCU Space Program, the first such endeavor in South Carolina.
  • The CCU Space Program will allow students to develop strong job-transferrable skills and may inspire the next generation of explorers.”
    Through this program, space technology will be levered to conduct scientific research aimed at addressing pressing issues in the management of the coastal environment and focus on monitoring and managing coastal erosion, sea-level rise, stormwater runoff, and other ecological concerns critical to the health of South Carolina’s coastal regions.
  • The CCU Space Program will offer an innovative and educational experience for students in intelligence and security studies.
  • In addition, the program will play a crucial role in safeguarding and managing cultural heritage assets, thus preserving South Carolina’s rich history.

Duke Energy supports first responders with $500,000 in grant opportunities for emergency preparedness in South Carolina

Retrieved on: 
tisdag, februari 27, 2024
Weather, Multimedia, News, Carbon accounting, Duke Energy, Radio, Nature, Hydrogen, Communication, Carbon, Emergency, Safety, Microgrant, Application, Palmetto, Electricity

"These grants will help provide our fellow first responders with the tools and training to handle whatever Mother Nature throws our way."

Key Points: 
  • "These grants will help provide our fellow first responders with the tools and training to handle whatever Mother Nature throws our way."
  • The Duke Energy Foundation provides more than $30 million annually in philanthropic support to meet the needs of communities where Duke Energy customers live and work.
  • Duke Energy (NYSE: DUK), a Fortune 150 company headquartered in Charlotte, N.C., is one of America's largest energy holding companies.
  • Its electric utilities serve 8.2 million customers in North Carolina, South Carolina, Florida, Indiana, Ohio and Kentucky, and collectively own 50,000 megawatts of energy capacity.

New report published by AAKP exposes alarming Medicare paradox: CMS private contractor limits Medicare, as BlueCross BlueShield expands coverage for transplant patients

Retrieved on: 
måndag, februari 12, 2024
Human services, Second Continental Congress, Anna Eshoo, CMS, Transplant, Kidney, Gift, Letter, Risk, House, Private sector, The Wall Street Journal, Medicare, Palmetto, Patient, Congress, Representative, Hispanic and Latino Americans, Congressional Black Caucus, Health insurance

WASHINGTON, Feb. 12, 2024 /PRNewswire/ -- Health Equity in Transplantation Coalition (HEiTC) Executive Chairman Al B. Sure! issued the following statement on the findings of a new report issued this week by the American Association of Kidney Patients (AAKP). 

Key Points: 
  • issued the following statement on the findings of a new report issued this week by the American Association of Kidney Patients (AAKP).
  • Yet incredibly, only months later, BlueCross BlueShield of South Carolina, which owns MolDX contractor Palmetto GBA, issued a favorable medical coverage decision that allows their BCBS South Carolina private insurance patients – but not Medicare patients – to have robust coverage and access to these transplant rejection tests.
  • "HEiTC is alarmed by the findings of AAKP's report, which highlights a clear divide and double standard between public healthcare and the private sector.
  • The AAKP report only underscores why the entire transplant community and the U.S. Congress must hear a thorough, honest explanation from CMS — immediately."

Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay

Retrieved on: 
tisdag, januari 16, 2024
Research, Medical Devices, Genetics, Other Health, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, MSI, LCD, Patient, Form 1095, PSNL, DNA, Medicare, RNA, DX, TMB, Genomics, NeXT, Transcriptome, Microsatellite instability, FDA, Biomarker, Palmetto, Clinical trial, Physician, Health insurance

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced it has received a final Medicare coverage determination for its NeXT Dx ultra-comprehensive tumor genomic profiling assay , providing access for the nation’s 66 million Medicare and Medicare Advantage beneficiaries.

Key Points: 
  • Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced it has received a final Medicare coverage determination for its NeXT Dx ultra-comprehensive tumor genomic profiling assay , providing access for the nation’s 66 million Medicare and Medicare Advantage beneficiaries.
  • Matching patients to their optimal cancer therapy requires a testing platform that can accurately report a broader range of clinically actionable genomic alterations.
  • Coverage for NeXT DX was extended effective August 29, 2023, under the Palmetto GBA MolDx program foundational Local Coverage Determination (LCD) L38119 (“Next-Generation Sequencing for Solid Tumors”).
  • Personalis estimates that approximately half of new solid tumor cancer cases will be diagnosed in patients covered by Medicare.

Naveris Receives Medicare Coverage for NavDx® Test

Retrieved on: 
torsdag, november 30, 2023
Oncology, Medical Supplies, Health, Health Technology, Health Insurance, Biotechnology, Palmetto, DNA, Head, TTMV, Patient, MRD, MD, Diagnosis, Medicare, Doctor of Philosophy, Cancer, Recurrence, Physician, Raoul de Navery

Naveris, Inc. , the leader in precision oncology diagnostics for viral-induced cancers, today announced that Palmetto GBA, the Medicare Administrative Contractor that administers the Molecular Diagnostics Services program (MolDX®), established Medicare coverage for NavDx®, Naveris’ proprietary flagship blood test for Tumor Tissue Modified Viral (TTMV®)-HPV DNA.

Key Points: 
  • Naveris, Inc. , the leader in precision oncology diagnostics for viral-induced cancers, today announced that Palmetto GBA, the Medicare Administrative Contractor that administers the Molecular Diagnostics Services program (MolDX®), established Medicare coverage for NavDx®, Naveris’ proprietary flagship blood test for Tumor Tissue Modified Viral (TTMV®)-HPV DNA.
  • NavDx is the first and only clinically validated circulating TTMV-HPV DNA blood test.
  • “This decision underscores the powerful clinical utility of Naveris’ TTMV platform and comes at a time of significant company momentum,” said James McNally, Chief Executive Officer of Naveris.
  • “Medicare coverage and future reimbursement will increase patient access to NavDx and we look forward to continued access expansion through commercial channels in the near future.”